Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...

Wild axolotls are facing extinction. That’s the bad news. But take heart: Cutie-pie axolotls bred in captivity may be able to ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...

Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from ...

Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular ...

Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Scientific uncertainty persists around 3I/ATLAS after anomalous observations and a CIA FOIA response, despite NASA’s public ...

The consequences could be severe. With paylines at most NIH Institutes well below 10 percent, every award not based on merit ...

For decades, television advertising has been a game of creativity and repetition. Jingles and mascots became part of our ...

Christopher Nolan’s Interstellar created a black hole that would later turn out to be fairly scientifically accurate.